Browse by UCL people
Group by: Type | Date
Number of items: 21.
2023
Mistry, Vijay;
Scott, Justin R;
Wang, Tzu-Yang;
Mollee, Peter;
Miles, Kenneth A;
Law, W Phillip;
Hapgood, Greg;
(2023)
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
Cancer Imaging
, 23
, Article 11. 10.1186/s40644-023-00520-7.
|
Weir-McCall, JR;
Debruyn, E;
Harris, S;
Qureshi, NR;
Rintoul, RC;
Gleeson, FV;
Gilbert, FJ;
... Pottinger, G; + view all
(2023)
Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
Chest
, 163
(2)
pp. 444-454.
10.1016/j.chest.2022.08.2227.
|
2022
Gilbert, Fiona J;
Harris, Scott;
Miles, Kenneth A;
Weir-McCall, Jonathan R;
Qureshi, Nagmi R;
Rintoul, Robert C;
Dizdarevic, Sabina;
... George, Steve; + view all
(2022)
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
Health Technology Assessment
, 26
(17)
10.3310/WCEI8321.
|
Gilbert, Fiona J;
Harris, Scott;
Miles, Kenneth A;
Weir-McCall, Jonathan R;
Qureshi, Nagmi R;
Rintoul, Robert Campbell;
Dizdarevic, Sabina;
... George, Steve; + view all
(2022)
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Thorax
, 77
(10)
pp. 988-996.
10.1136/thoraxjnl-2021-216948.
|
2021
Chen, S-H;
Miles, K;
Taylor, SA;
Ganeshan, B;
Rodriquez, M;
Fraioli, F;
Wan, S;
... Groves, A; + view all
(2021)
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05318-y.
(In press).
|
Ganeshan, B;
Miles, K;
Afaq, A;
Punwani, S;
Rodriguez, M;
Wan, S;
Walls, D;
... Groves, A; + view all
(2021)
Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer.
Cancers
, 13
(11)
, Article 2715. 10.3390/cancers13112715.
|
2020
Ladwa, Rahul;
Roberts, Kate E;
O'Leary, Connor;
Maggacis, Nicole;
O'Byrne, Kenneth J;
Miles, Kenneth;
(2020)
Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer.
Lung Cancer Management
, 9
(3)
, Article LMT38. 10.2217/lmt-2020-0002.
|
Weir-McCall, JR;
Harris, S;
Miles, KA;
Qureshi, NR;
Rintoul, RC;
Dizdarevic, S;
Pike, L;
... Pottinger, G; + view all
(2020)
Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-020-05089-y.
(In press).
|
2018
Miles, KA;
Squires, J;
Murphy, M;
(2018)
Radiologist Engagement as a Potential Barrier to the Clinical Translation of Quantitative Imaging for the Assessment of Tumor Heterogeneity.
Academic Radiology
, 25
(7)
pp. 935-942.
10.1016/j.acra.2017.11.019.
|
Miles, KA;
Voo, SA;
Groves, AM;
(2018)
Additional Clinical Value for PET/MRI in Oncology: Moving Beyond Simple Diagnosis.
The Journal of Nuclear Medicine
, 59
(7)
pp. 1028-1032.
10.2967/jnumed.117.203612.
|
Oh, G;
Miles, K;
(2018)
Subacute Cerebellar Infarction With Uptake on 68Ga–Prostate-Specific Membrane Antigen PET/CT.
Presented at: Clinical Nuclear Medicine.
|
2017
Afaq, A;
Fraioli, F;
Sidhu, H;
Wan, S;
Punwani, S;
Chen, S-H;
Akin, O;
... Kayani, I; + view all
(2017)
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Clinical Nuclear Medicine
, 42
(1)
e1-e7.
10.1097/RLU.0000000000001344.
|
Bates, A;
Miles, K;
(2017)
Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer.
European Radiology
, 27
(12)
pp. 5290-5298.
10.1007/s00330-017-4877-x.
|
Craigie, M;
Squires, J;
Miles, K;
(2017)
Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer.
Clinical Radiology
, 72
(10)
899.e1-899.e7.
10.1016/j.crad.2017.04.013.
|
Ganeshan, B;
Miles, KA;
Babikir, S;
Shortman, R;
Afaq, A;
Ardeshna, KM;
Groves, AM;
(2017)
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
European Radiology
, 27
(3)
pp. 1012-1020.
10.1007/s00330-016-4470-8.
|
Joshi, A;
Nicholson, C;
Rhee, H;
Gustafson, S;
Miles, K;
Vela, I;
(2017)
Incidental Malignancies Identified During Staging for Prostate Cancer With Ga-68 Prostate-specific Membrane Antigen HBED-CC Positron Emission Tomography Imaging.
Urology
, 104
e3-e4.
10.1016/j.urology.2017.03.018.
|
Makanyanga, J;
Ganeshan, B;
Rodriguez-Justo, M;
Bhatnagar, G;
Groves, A;
Halligan, S;
Miles, K;
(2017)
MRI texture analysis (MRTA) of T2-weighted images in Crohn's disease may provide information on histological and MRI disease activity in patients undergoing ileal resection.
European Radiology
, 27
(2)
pp. 589-598.
10.1007/s00330-016-4324-4.
|
2016
O'Connor, JP;
Aboagye, EO;
Adams, JE;
Aerts, HJ;
Barrington, SF;
Beer, AJ;
Boellaard, R;
... Waterton, JC; + view all
(2016)
Imaging biomarker roadmap for cancer studies.
Nat Rev Clin Oncol
10.1038/nrclinonc.2016.162.
(In press).
|
Qureshi, NR;
Rintoul, RC;
Miles, KA;
George, S;
Harris, S;
Madden, J;
Cozens, K;
... Gilbert, FJ; + view all
(2016)
Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.
BMJ Open Respiratory Research
, 3
(1)
, Article e000156. 10.1136/bmjresp-2016-000156.
|
Qureshi, NR;
Shah, A;
Eaton, RJ;
Miles, K;
Gilbert, FJ;
(2016)
Dynamic contrast enhanced CT in nodule characterization: How we review and report.
Cancer Imaging
, 16
(1)
, Article 16. 10.1186/s40644-016-0074-4.
|
2015
Miles, K;
McQueen, L;
Ngai, S;
Law, P;
(2015)
Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology.
Cancer Imaging
, 15
(1)
10.1186/s40644-015-0053-1.
|